As tensions in the Middle East continue to evolve, multinational employers are being reminded how quickly regional instability can have a ripple effect. Healthcare systems, provider access, and supply chains do not operate in isolation, and neither do the risks employers face.
And heading into 2026, we were already faced with consistent pressure across markets. What we have been seeing is medical inflation is not confined to one region or one type of plan. It is global, it is persistent, and it is increasingly driven by market circumstances, high-cost conditions and treatments.
Insurope’s Global Employee Benefits and Multinational Pooling Market Report confirmed benefit costs are at the top of HR leaders’ minds globally, with nearly half naming cost pressures their biggest challenge. But let’s look at what other sources have to say:
Even where the trend is “cooling,” it is cooling from levels that were already warm.
One of the most important takeaways for multinational employers is how widely medical cost pressure can vary by country, even within the same region. For example, in the United States, PwC projects a 2026 medical cost trend of 8.5% for the group market (and 7.5% for individual). Similarly, HUB projects that total benefit costs for 2026 will rise about 8 %–10 % nationally, with trends for medical and prescription drug coverage combined in that range.
And, WTW’s Asia Pacific analysis, projected gross medical trend rates for 2026 include:
This spread is exactly why employers need global coordination, combined with local precision.
Insurope’s own Risk Insight Survey from December 2025 confirms that these global pressures are already being felt across the Network. Among our Network Members, Medical is now the most challenged benefit where they cite the primary drivers as cancer and oncology (55 percent), cardiovascular disease (32 percent), respiratory conditions (32 percent), and mental and behavioral health (35 percent).
Other drivers include new medical technologies and higher utilization, the rising use and cost of pharmaceuticals including GLP-1 drugs and lifestyle-linked risk factors such as hypertension, inactivity, and nutrition – making preventative care and wellbeing more important than ever.
When medical costs rise in multiple markets at once, multinational pooling becomes more valuable, not less.
Pooling is often described as a financial mechanism, but for multinational employers it is also a governance mechanism. Done well, it helps you manage volatility, improve visibility, and create a disciplined approach to benefits oversight across countries.
Three ways pooling can help offset rising medical costs:
The other half of the equation: the right local insurers
Financial structure helps. But it is not enough on its own.
Rising medical costs are increasingly tied to preventable or manageable conditions. That makes local capabilities critical. Strong local insurers, like Insurope’s Network Members, can deliver on-the-ground programs that actually change outcomes, including:
In the end, medical cost inflation is not going away in 2026. The question is whether employers face it market by market, or whether they use a smarter structure that combines global oversight with local execution.
This is exactly why we focus on at Insurope, THE Premier Multinational Pooling Network: helping multinationals manage risk, and access strong local expertise across markets, so benefits remain sustainable for the business and meaningful for employees.
To learn more about our trends in employee benefits across the globe, request a copy of our Global Employee Benefits and Multinational Pooling Market Report here.